N Engl J Med January 2004 PMID 14749457

Risks of testosterone-replacement therapy and recommendations for monitoring.

Ernani Luis Rhoden, Abraham Morgentaler

Mentions

14
Peak: 6 in Oct 2022
across 4 sources since May 2022

Extended reach

114,971
potential audience

Total likes

73

Video views

1,412

Mentions per month

May 2022 – Aug 2025

Where it's discussed

  • X / Twitter7 posts
  • Blogs3 articles
  • YouTube2 videos
  • News2 articles

AI synopsis

What people are saying

The discussions mention a good table summarizing TRT risks from a 2004 study, indicating an interest in data-driven information. Phrases like 'of note' and comments on how views have 'only become more favorable' suggest a neutral tone that balances recognition of risks with evolving perspectives, showing moderate engagement and impact.

AgreementNeither agree nor disagree

The discussions show a neutral stance; some recognize the risks but acknowledge the evolving perspective on TRT risks and benefits.

InterestModerate interest

The conversations indicate moderate interest, focusing on a specific table and risk factors without deep exploration.

EngagementModerate engagement

Posts reference data and conclusions but lack detailed analysis or emotional tone, reflecting moderate engagement.

ImpactNeutral impact

The overall impact appears limited, with discussions mainly centered on data and risk perspectives rather than immediate clinical changes.

Abstract in brief

  • Testosteronereplacement therapy (TRT) can pose risks such as increased chances of cardiovascular issues, sleep apnea, and potential stimulation of prostate growth, requiring careful patient selection and monitoring.
  • Regular monitoring should include tracking hormone levels, blood counts, prostate health, and cardiovascular risk factors to prevent complications.
  • Medical professionals are advised to weigh the benefits against risks and follow guidelines to ensure safe and effective TRT management.]

Top posts

Most liked on X and Bluesky
BowTiedLoon | Degen Island Physician
@BowTiedLoon · X

Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and prostate cancer risks have only become more favorable towards TRT. https://t.co/IaNztMLQMG

Oct 12, 2022 · 34 likes · 5 shares · 11,156 followers View post →
BowTiedOx | SOF Athlete/Bodybuilder
@BowTiedOx · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 86,122 followers View post →
SilverFoxLeo
@BowTiedHRT · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 13,591 followers View post →
Texican
@PewyF · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 1,161 followers View post →
Elton John Candy
@silla_de_pensar · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 619 followers View post →
Leopoldo Santos-Neto
@leosantosIII · X

Em tempos de modismo, o clínico deve permanecer atento e monitorar os pacientes devido aos riscos cardiovasculares, endócrinos e psiquiátricos envolvidos. (

Mar 18, 2025 · 591 followers View post →

All mentions

Leopoldo Santos-Neto
@leosantosIII · X

Em tempos de modismo, o clínico deve permanecer atento e monitorar os pacientes devido aos riscos cardiovasculares, endócrinos e psiquiátricos envolvidos. (

Mar 18, 2025 · 591 followers View post →
Elton John Candy
@silla_de_pensar · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 619 followers View post →
The Great White Snark
@great_wh_snark · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 260 followers View post →
BowTiedOx | SOF Athlete/Bodybuilder
@BowTiedOx · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 86,122 followers View post →
Texican
@PewyF · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 1,161 followers View post →
SilverFoxLeo
@BowTiedHRT · X

RT @BowTiedLoon: Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and pro…

Oct 12, 2022 · 5 shares · 13,591 followers View post →
BowTiedLoon | Degen Island Physician
@BowTiedLoon · X

Good table on risks of TRT (from 2004 NEJM paper: https://t.co/aMLF2wPlm7) Of note, over time, views on CVD risk and prostate cancer risks have only become more favorable towards TRT. https://t.co/IaNztMLQMG

Oct 12, 2022 · 34 likes · 5 shares · 11,156 followers View post →